EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant

Michael D Fox iD, Sumukh Kumar iD, Allison D Britt iD, Abhay S Srinivasan iD, Lea F Surrey, Seth E Vatsky, Alexandra J Borst, Hakon Hakonarson, Dong Li, Sarah E Sheppard, Kristen M Snyder, Denise M Adams

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.32015 ↗

At a glance

Journal article in Pediatric Blood & Cancer, 2025. Written by Michael D Fox and 11 co-authors. Institution: Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Proto-Oncogene Proteins B-raf, Lymphatic Abnormalities, Mutation. 21 references. The full text is freely available (open access, CC BY 4.0). Funded by: Intramural NIH HHS, Intramural Research Program of the National Institutes of Health (NIH).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The somatic activating variant in BRAF (p.V600E) was recently described as a novel cause of macrocystic head and neck lymphatic malformations in three individuals. Other recent studies profiling the genetic causes of more complex lymphatic anomalies identified this same pathogenic BRAF variant. Our aim was to expand the phenotypic description of the somatic BRAF p.V600E variant in individuals with vascular anomalies. Procedure We searched the database of individuals with vascular anomalies at our institution for those identified as having complex lymphatic anomalies and somatic BRAF p.V600E variants. A comprehensive retrospective review of identified individuals’ electronic health records was conducted.

Results

Six individuals with complex lymphatic anomalies had the BRAF p.V600E variant. All individuals had diffuse lymphatic malformations and abnormal lymphatic conduction. The conduction abnormalities were observed only after surgical interventions in five of the patients, in some cases, manifesting years later. There was immense phenotypic heterogeneity within the cohort.

Conclusions

Complex lymphatic anomalies are an important new phenotype associated with the pathogenic BRAF p.V600E variant. Even in initially asymptomatic individuals within this patient population, longitudinal follow‐up is necessary, and surgical intervention should be pursued with caution. Further investigation is needed to better understand the etiology of the conduction problems associated with this pathogenic variant to inform the multidisciplinary approach to treatment.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins B-rafLymphatic AbnormalitiesMutationHumansMaleFemalePhenotypeRetrospective StudiesChild, PreschoolChildInfantAdolescentFollow-Up StudiesPrognosis

Author keywords

BRAFcentral conducting lymphatic anomalycomplex lymphatic anomalygeneralized lymphatic anomalykaposiform lymphatic anomaly

Substances

Proto-Oncogene Proteins B-rafBRAF protein, human

Authors and institutions

  • Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Comprehensive Vascular Anomalies Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Interventional Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Division of Pediatric Hematology-Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID profiles: Michael D Fox, Sumukh Kumar, Allison D Britt, Abhay S Srinivasan

Funding

  • Intramural NIH HHS
  • Intramural Research Program of the National Institutes of Health (NIH)

Cite

APA

Fox, M. D., Kumar, S., Britt, A. D., Srinivasan, A. S., Surrey, L. F., Vatsky, S. E., Borst, A. J., Hakonarson, H., Li, D., Sheppard, S. E., Snyder, K. M., & Adams, D. M. (2025). Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32015

Vancouver

Fox MD, Kumar S, Britt AD, Srinivasan AS, Surrey LF, Vatsky SE, et al. Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.32015

BibTeX
@article{Fox2025,
  author = {Fox, Michael D and Kumar, Sumukh and Britt, Allison D and Srinivasan, Abhay S and Surrey, Lea F and Vatsky, Seth E and Borst, Alexandra J and Hakonarson, Hakon and Li, Dong and Sheppard, Sarah E and Snyder, Kristen M and Adams, Denise M},
  title = {Expansion of the Phenotype of Lymphatic Anomalies Caused by Somatic Activating BRAF Variant},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.32015}
}
Start for free →